Cohen Yuval

Cohen Yuval is listed in filings as Chief Executive Officer at Corbus Pharmaceuticals Holdings, Inc.. This profile follows SEC Form 4 activity through Feb 18, 2026, including sale activity. Recent filings connect the profile to Corbus Pharmaceuticals Holdings, Inc. (CRBP). The current snapshot covers public activity from Jun 18, 2024 to Feb 18, 2026. Reported amounts are shown as $108.0K to $153.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.